Great News from Italy and the UK, Chinese-developed V-CLAMP Made Its Remarkable Debut in Europe

  • 2022.05.12
  • source:Hongyu Medical

V-Clamp is a device developed by Hongyu Medical to treat dogs with mitral regurgitation. It has gained attention from international veterinary industry since its launch. Many top veterinary medical institutions and experts showed huge interest in this new technology.

On May 2nd, 2022, with the technical guidance and support from Dr. Christopher Orton and Dr. Brianna M Potter from CSU, Clinica Veterinaria Gran Sasso from Italy successfully performed the first heart valve procedure with V-Clamp in Europe. On May 5th, 2022, Langford Vets from the UK also successfully performed 2 cases. This marks that the new mitral regurgitation treatment was officially introduced to Europe.

The first case in Europe——A 7 year-old King Charles spaniel


Comments from the veterinarian

“We did two successful V-Clamp cases with Dr. Borgeat‘s team in the UK. Both cases had an excellent recovery. In our opinion the UK is fully trained and ready to do cases on their own. I believe they are ready to do more cases as soon as they can receive devices.

We did one successful V-Clamp case with Dr. Bussadori’s team in Italy. This dog had a dramatic improvement in heart size and an excellent recovery. The dog was discharged from the hospital the day after surgery.”

Italy team introduction

Clinica Veterinaria Gran Sasso


Clinica Veterinaria Gran Sasso was founded by Dr. Maria Cristina Crosta and Dr. Claudio Bussadori in 1986. On December 3rd, 1998, the headquarter was established covered 900 ㎡. It provides 24/7 emergency treatment and resident services.


Dr. Claudio Bussadori
1993 ECVIM ca (cardiology)
1993-1999 Vice President of ECVIM
1997-1999 President of ESVC
2022 Honorable Board Member of ESVC


Dr. Claudio Bussadori works as clinician and cardiology consultant at Clinica Veterinaria Gran Sasso, director of ECVIM cardiology program, and researcher of pediatric heart disease at S.Donato Hospital. Research areas: canine and human ultrasonic cardiogram and congenital heart diseases treatment. Publishing: 163 articles on medical and veterinary periodicals including original articles, abstract from conferences and chapters from books.

 UK team introduction

Langford Vets  


Langford Vets is a group of customer focused veterinary businesses providing an extensive range of specialist capabilities and a superior quality of care. We have the largest team of American and European Specialists in the south west of England. We are members of the Royal College of Veterinary Surgeons Practice Standards Scheme. Proud to be a part of the University of Bristol. At the forefront of discovery, at the heart of animal care.


Kieran Borgeat


Kieran graduated from the University of Bristol in 2005 and worked in general practice for 6 years. There, he achieved his RCVS Certificate in Veterinary Cardiology and enjoyed a range of cases from orthopaedics to internal medicine and dermatology. He undertook a Residency and combined Masters degree at the Royal Veterinary College in London. He has been working full-time in cardiology (small animal, farm and equine) since 2011 and holds ACVIM and ECVIM Diplomate status, in addition to being accredited as an RCVS Specialist. He has published widely to further our understanding of feline heart disease, and has spoken all over the world on feline cardiology. He also has a particular interest in interventional cardiovascular techniques and congenital heart disease. As Clinical Lead in Cardiology at Langford Vets, Bristol, Kieran works 85% in the clinic and sees primary cases as well as training the next generation of specialists in cardiology.


About Hongyu Medical

Shanghai Hongyu Medical Technology Co.,Ltd. is the world's first company to develop R & D of mitral regurgitation medical devices for pet dogs. The core product is an independently developed mitral valve interventional repair device V-Clamp.

About V-Clamp

The product is based on the principle of transcatheter edge-to-edgemitral valve repair, which has been widely used in human medicine and proved to be safe and effective. The human application of the product has also shown satisfactory results. Structural technology Multiple sizes of devices can be selected for various dogs. Multiple clamps can be implanted to enhance the effect of procedure. Minimally invasive advantages No cardiac arrest is required, with minimal trauma and fast recovery. The catheter is only 10F or 14F. The device can be repeatedly clamped, and the clamping position is adjustable without damaging the leaflets.